Characterization of a live-attenuated HCMV-based vaccine platform.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
17 12 2019
17 12 2019
Historique:
received:
22
08
2019
accepted:
29
11
2019
entrez:
19
12
2019
pubmed:
19
12
2019
medline:
5
11
2020
Statut:
epublish
Résumé
Vaccines based on cytomegalovirus (CMV) demonstrate protection in animal models of infectious disease and cancer. Vaccine efficacy is associated with the ability of CMV to elicit and indefinitely maintain high frequencies of circulating effector memory T cells (T
Identifiants
pubmed: 31848362
doi: 10.1038/s41598-019-55508-w
pii: 10.1038/s41598-019-55508-w
pmc: PMC6917771
doi:
Substances chimiques
Cytomegalovirus Vaccines
0
Vaccines, Attenuated
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19236Subventions
Organisme : NIH HHS
ID : P51 OD011092
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI054292
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI095113
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI094417
Pays : United States
Références
J Gen Virol. 2009 Oct;90(Pt 10):2386-2394
pubmed: 19553394
Nature. 2013 Oct 3;502(7469):100-4
pubmed: 24025770
J Mol Biol. 1967 Jun 14;26(2):365-9
pubmed: 4291934
J Virol. 2006 Jun;80(12):6188-91
pubmed: 16731959
J Virus Erad. 2016 Oct 5;2(4):198-207
pubmed: 27781101
mBio. 2014 Oct 28;5(6):e02035
pubmed: 25352622
Cell Host Microbe. 2017 Feb 8;21(2):231-243
pubmed: 28132838
J Gen Virol. 2010 Mar;91(Pt 3):599-604
pubmed: 19906945
Mol Ecol. 2017 Apr;26(7):1980-1990
pubmed: 27988973
Science. 2010 Apr 2;328(5974):102-6
pubmed: 20360110
Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):18021-18030
pubmed: 31427511
Curr Opin Immunol. 2017 Aug;47:52-56
pubmed: 28734175
PLoS Pathog. 2011 Oct;7(10):e1002295
pubmed: 21998590
Nat Med. 2009 Mar;15(3):293-9
pubmed: 19219024
Science. 2013 May 24;340(6135):1237874
pubmed: 23704576
Hum Mol Genet. 2016 Apr 15;25(R1):R42-52
pubmed: 26519140
J Virol Methods. 2002 Jul;104(2):135-46
pubmed: 12088823
J Virol. 1993 Sep;67(9):5595-604
pubmed: 8394462
Nature. 2011 May 26;473(7348):523-7
pubmed: 21562493
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7043-7052
pubmed: 30894498
J Exp Med. 2017 Jul 3;214(7):1889-1899
pubmed: 28566275
Curr Opin Virol. 2015 Aug;13:86-92
pubmed: 26118890
J Virol. 2008 Jan;82(1):60-70
pubmed: 17942555
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3263-8
pubmed: 12626766
Pediatr Rev. 2002 May;23(5):163-70
pubmed: 11986492
J Virol. 2012 Nov;86(21):11425-33
pubmed: 22915800
J Infect Dis. 2016 Nov 1;214(9):1341-1348
pubmed: 27521362
Nat Med. 2018 Feb;24(2):130-143
pubmed: 29334373
Science. 1998 Jan 16;279(5349):349-52
pubmed: 9454332
J Clin Invest. 2010 Sep;120(9):3191-208
pubmed: 20679731
J Virol. 2013 Oct;87(19):10489-500
pubmed: 23885075
Immunity. 1997 May;6(5):613-21
pubmed: 9175839
J Virol. 2005 May;79(10):6419-31
pubmed: 15858025
PLoS Pathog. 2016 Nov 9;12(11):e1006014
pubmed: 27829026
J Clin Virol. 2006 Mar;35(3):332-7
pubmed: 16387547
J Virol. 2002 Mar;76(5):2316-28
pubmed: 11836410
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):E9889-E9898
pubmed: 30275317
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14506-11
pubmed: 11121054
Future Virol. 2012 Sep 1;7(9):855-869
pubmed: 23378857
Sci Transl Med. 2019 Jul 17;11(501):
pubmed: 31316006
mBio. 2018 May 8;9(3):
pubmed: 29739904
Genomics. 2001 Apr 1;73(1):56-65
pubmed: 11352566
J Virol. 2010 Jun;84(11):5594-604
pubmed: 20335255
J Virol. 2005 Aug;79(16):10330-8
pubmed: 16051825
PLoS Pathog. 2011 Dec;7(12):e1002444
pubmed: 22241980
Science. 2016 Feb 12;351(6274):714-20
pubmed: 26797147
J Virol. 2014 Jan;88(1):403-16
pubmed: 24155395
J Virol. 2010 Oct;84(19):9853-63
pubmed: 20686028
Vaccine. 2019 Oct 16;37(44):6696-6706
pubmed: 31548012
J Virol. 1999 Jul;73(7):5757-66
pubmed: 10364327
PLoS One. 2019 Jan 23;14(1):e0210252
pubmed: 30673723
J Gen Virol. 2010 Jun;91(Pt 6):1535-46
pubmed: 20479471
Cell. 2018 Aug 23;174(5):1158-1171.e19
pubmed: 30057110
Nat Med. 2018 Sep;24(9):1430-1440
pubmed: 30082858
mBio. 2016 Mar 01;7(2):e01986
pubmed: 26933055
J Virol. 2010 Aug;84(15):7730-42
pubmed: 20463067
Nucleic Acids Res. 2005 Feb 24;33(4):e36
pubmed: 15731329
Virology. 2008 Mar 30;373(1):181-8
pubmed: 18068749
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5693-5698
pubmed: 30819890
J Virol. 2004 Sep;78(18):10023-33
pubmed: 15331735
Med Microbiol Immunol. 2015 Jun;204(3):273-84
pubmed: 25894764
Med Microbiol Immunol. 2019 Aug;208(3-4):349-363
pubmed: 30900089
Sci Transl Med. 2019 Jul 17;11(501):
pubmed: 31316007
J Virol. 2005 Jun;79(12):7792-802
pubmed: 15919932
Sci Transl Med. 2016 Oct 26;8(362):362ra145
pubmed: 27797961
Immunol Rev. 2018 May;283(1):99-112
pubmed: 29664577
J Virol. 2006 Apr;80(8):3863-71
pubmed: 16571803
Vaccine. 2012 Dec 14;30(52):7469-74
pubmed: 23107592
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14976-81
pubmed: 14657367
Arch Ophthalmol. 1998 Feb;116(2):178-85
pubmed: 9488269
Cell Rep. 2018 Jul 17;24(3):594-606
pubmed: 30021158
J Virol. 2011 May;85(10):5105-14
pubmed: 21389128
PLoS Pathog. 2016 Aug 31;12(8):e1005868
pubmed: 27580123
PLoS One. 2012;7(8):e41936
pubmed: 22870265
J Gen Virol. 2006 May;87(Pt 5):1113-1121
pubmed: 16603511
mSphere. 2017 Oct 4;2(5):
pubmed: 28989973
Mol Cell Biol. 2003 Mar;23(6):1885-95
pubmed: 12612064
Cell Host Microbe. 2010 Sep 16;8(3):284-91
pubmed: 20833379